Fund shareholders of Revolution Medicines Inc
ISIN US76155X1000 · United States · LEI 549300JU3X0LBCQ65892
- Fund shareholders
- 420
- Of which ETFs
- 98 322 other funds
- Value held
- 5.1B $ 404.1M SEK · 677.8K €
- Share of capital
- 22.6 % of 214.3M shares on Jul 31, 2026
This issuer has other securities : REVOLUTION MEDICINES INC WTS 12/26 (US76155X1182)
420 funds hold this company. This table lists the 419 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5,982,719 | 581.8M $ | 0.03 % | 2.79 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 4,341,039 | 422.2M $ | 0.26 % | 2.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,511,042 | 256.2M $ | 0.31 % | 1.17 % | as of Feb 28, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2,428,562 | 236.2M $ | 0.61 % | 1.13 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,028,710 | 197.3M $ | 0.24 % | 0.95 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1,838,404 | 265M $ | 0.72 % | 0.86 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,519,722 | 147.8M $ | 1.36 % | 0.71 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,283,912 | 124.9M $ | 1.54 % | 0.60 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 1,088,018 | 105.8M $ | 2.04 % | 0.51 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Enterprise Fund JANUS INVESTMENT FUND | 999,703 | 97.2M $ | 0.48 % | 0.47 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 950,460 | 97M $ | 0.24 % | 0.44 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 881,994 | 90M $ | 0.43 % | 0.41 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 850,768 | 82.7M $ | 1.11 % | 0.40 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 697,132 | 71.1M $ | 0.31 % | 0.33 % | as of Feb 28, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 664,483 | 95.8M $ | 0.19 % | 0.31 % | as of Apr 30, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 648,760 | 63.1M $ | 0.13 % | 0.30 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 611,402 | 62.4M $ | 0.30 % | 0.29 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Triton Fund JANUS INVESTMENT FUND | 554,682 | 53.9M $ | 1.04 % | 0.26 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 534,794 | 77.1M $ | 0.35 % | 0.25 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Growth Leaders Fund LORD ABBETT SECURITIES TRUST | 526,650 | 75.9M $ | 1.00 % | 0.25 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Research Fund JANUS INVESTMENT FUND | 502,273 | 48.8M $ | 0.20 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 491,502 | 50.1M $ | 0.37 % | 0.23 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 438,772 | 44.8M $ | 0.84 % | 0.20 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 420,864 | 42.9M $ | 0.21 % | 0.20 % | as of Feb 28, 2026 ↗ |
| iShares Russell 1000 Value ETF iShares Trust | 390,206 | 37.9M $ | 0.05 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Venture Fund JANUS INVESTMENT FUND | 371,147 | 36.1M $ | 1.18 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 340,410 | 34.7M $ | 0.03 % | 0.16 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 329,504 | 32M $ | 0.25 % | 0.15 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 302,995 | 30.9M $ | 0.47 % | 0.14 % | as of Feb 27, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 299,500 | 43.2M $ | 2.27 % | 0.14 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 297,400 | 28.9M $ | 0.13 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 269,567 | 27.5M $ | 0.03 % | 0.13 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 268,963 | 26.2M $ | 0.32 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 257,218 | 25M $ | 1.58 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Columbia Cornerstone Growth Fund COLUMBIA FUNDS SERIES TRUST I | 255,336 | 36.8M $ | 0.57 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Franklin Dynatech Fund Franklin Custodian Funds | 250,000 | 24.3M $ | 0.10 % | 0.12 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap Value ETF iShares Trust | 244,314 | 23.8M $ | 0.17 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 240,648 | 34.7M $ | 0.08 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 233,284 | 33.6M $ | 0.66 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Contrarian Fund JANUS INVESTMENT FUND | 232,000 | 22.6M $ | 0.53 % | 0.11 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 231,188 | 22.5M $ | 0.03 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Marsico Midcap Growth Focus Fund MARSICO INVESTMENT FUND | 219,460 | 21.3M $ | 3.22 % | 0.10 % | as of Mar 31, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 206,123 | 191M SEK | 0.01 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 202,430 | 29.2M $ | 2.82 % | 0.09 % | as of Apr 30, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 184,200 | 17.9M $ | 0.22 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Columbia Variable Portfolio - Select Large Cap Equity Fund Columbia Funds Variable Series Trust II | 167,301 | 16.3M $ | 0.53 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Columbia Variable Portfolio - Large Cap Growth Fund Columbia Funds Variable Series Trust II | 165,906 | 16.1M $ | 0.65 % | 0.08 % | as of Mar 31, 2026 ↗ |
| VANGUARD GLOBAL EQUITY FUND VANGUARD HORIZON FUNDS | 161,736 | 15.7M $ | 0.22 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Columbia Small Cap Growth Fund COLUMBIA FUNDS SERIES TRUST I | 159,280 | 16.2M $ | 0.51 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 152,378 | 22M $ | 1.56 % | 0.07 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 144,911 | 20.9M $ | 0.02 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 143,138 | 20.6M $ | 0.04 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Columbia Acorn Fund COLUMBIA ACORN TRUST | 135,489 | 13.2M $ | 0.59 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 133,786 | 13.6M $ | 1.11 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity OTC Portfolio Fidelity Securities Fund | 133,478 | 19.2M $ | 0.05 % | 0.06 % | as of Apr 30, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 133,298 | 19.2M $ | 0.87 % | 0.06 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 127,827 | 18.4M $ | 0.05 % | 0.06 % | as of Apr 30, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 123,083 | 12M $ | 0.03 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund Touchstone Strategic Trust | 120,829 | 11.8M $ | 0.65 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 115,532 | 16.7M $ | 0.04 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 113,330 | 11.6M $ | 0.05 % | 0.05 % | as of Feb 28, 2026 ↗ |
| iShares MSCI USA Momentum Factor ETF iShares Trust | 111,936 | 16.1M $ | 0.07 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 109,365 | 10.6M $ | 2.86 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 105,988 | 10.3M $ | 0.02 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 105,445 | 10.8M $ | 0.03 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 105,291 | 10.2M $ | 0.03 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Stock Selector Large Cap Value Fund Fidelity Devonshire Trust | 104,800 | 15.1M $ | 0.10 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 102,283 | 9.9M $ | 0.04 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 100,630 | 10.3M $ | 0.06 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 100,000 | 14.4M $ | 0.50 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 100,000 | 10.2M $ | 0.16 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 98,581 | 10.1M $ | 6.29 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Columbia Large Cap Growth Opportunity Fund COLUMBIA FUNDS SERIES TRUST | 97,956 | 10M $ | 0.83 % | 0.05 % | as of Feb 28, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 96,874 | 9.9M $ | 0.68 % | 0.05 % | as of Feb 27, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 94,717 | 9.2M $ | 0.01 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 94,253 | 13.6M $ | 0.04 % | 0.04 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 92,384 | 9M $ | 1.36 % | 0.04 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 92,101 | 13.3M $ | 0.47 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 90,657 | 8.8M $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Tax Managed Small/Mid Cap Fund Bridge Builder Trust | 86,676 | 8.4M $ | 0.28 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Next Gen 100 ETF Invesco Exchange-Traded Fund Trust II | 86,147 | 8.8M $ | 0.98 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Global Research Fund JANUS INVESTMENT FUND | 84,671 | 8.2M $ | 0.20 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 84,606 | 12.2M $ | 0.50 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Columbia Cornerstone Equity Fund COLUMBIA FUNDS SERIES TRUST | 82,763 | 8.4M $ | 0.54 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Enterprise Portfolio JANUS ASPEN SERIES | 81,697 | 7.9M $ | 0.47 % | 0.04 % | as of Mar 31, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 76,325 | 11M $ | 6.85 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity Small-Mid Multifactor ETF Fidelity Covington Trust | 76,291 | 11M $ | 0.46 % | 0.04 % | as of Apr 30, 2026 ↗ |
| JPMorgan BetaBuilders U.S. Mid Cap Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 75,406 | 10.9M $ | 0.54 % | 0.04 % | as of Apr 30, 2026 ↗ |
| JNL/Mellon Healthcare Sector Fund JNL Series Trust | 75,072 | 7.3M $ | 0.29 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 74,944 | 10.8M $ | 0.38 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Equity Factor Rotation Active ETF BlackRock ETF Trust | 74,577 | 10.7M $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 74,541 | 10.7M $ | 0.38 % | 0.03 % | as of Apr 30, 2026 ↗ |
| BlackRock Event Driven Equity Fund BlackRock Large Cap Series Funds, Inc. | 74,415 | 7.6M $ | 0.15 % | 0.03 % | as of Feb 27, 2026 ↗ |
| Janus Henderson Mid Cap Value Fund JANUS INVESTMENT FUND | 73,469 | 7.1M $ | 0.37 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Value Index Fund Fidelity Salem Street Trust | 72,963 | 10.5M $ | 0.08 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Small-Cap Equity Factor ETF iShares Trust | 68,108 | 9.8M $ | 0.27 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Nuveen Large Cap Value Index Fund TIAA-CREF Funds | 66,133 | 9.5M $ | 0.08 % | 0.03 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 65,625 | 6.4M $ | 0.15 % | 0.03 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 65,370 | 6.4M $ | 0.41 % | 0.03 % | as of Mar 31, 2026 ↗ |
| EQ/Janus Enterprise Portfolio EQ Advisors Trust | 64,466 | 6.3M $ | 0.47 % | 0.03 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 6.85 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 6.29 % | as of Feb 28, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.13 % | as of Mar 31, 2026 ↗ |
| Marsico Midcap Growth Focus Fund MARSICO INVESTMENT FUND | 3.22 % | as of Mar 31, 2026 ↗ |
| Pinnacle Focused Opportunities ETF Tidal Trust II | 3.15 % | as of Feb 28, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 2.98 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 2.86 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2.82 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Transformational Growth ETF Janus Detroit Street Trust | 2.41 % | as of Apr 30, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 2.38 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 400 | +41 | 47,949,343 | -6.1 % |
| 2026Q1 | 359 | +41 | 51,041,234 | -8.6 % |
| 2025Q4 | 318 | -18 | 55,857,845 | -6.5 % |
| 2025Q3 | 336 | +10 | 59,732,762 | -7.8 % |
| 2025Q2 | 326 | +4 | 64,794,405 | +3.7 % |
| 2025Q1 | 322 | +9 | 62,505,392 | +5.6 % |
| 2024Q4 | 313 | +26 | 59,209,688 | +5.5 % |
| 2024Q3 | 287 | +20 | 56,129,869 | +4.9 % |
| 2024Q2 | 267 | +18 | 53,490,879 | +17.6 % |
| 2024Q1 | 249 | +26 | 45,498,077 | +12.7 % |
| 2023Q4 | 223 | 40,365,735 |
Institutional managers
503 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 13,604,796 | 1.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 11,212,706 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 9,766,496 | 949.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 9,555,357 | 929.3M $ | as of Mar 31, 2026 |
| FMR LLC | 8,464,314 | 823.2M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 7,601,087 | 739.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 6,655,703 | 647.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 6,027,819 | 586.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,475,611 | 532.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,402,662 | 428.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 4,386,791 | 426.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,338,142 | 323.9M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 3,292,525 | 320.2M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,232,213 | 314.3K $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,856,782 | 277.8M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 2,577,333 | 250.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 2,506,570 | 243.8M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 2,468,644 | 240.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,375,000 | 231M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,344,444 | 228M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,297,000 | 223.4M $ | as of Mar 31, 2026 |
| Darwin Global Management, Ltd. | 2,211,018 | 205M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,185,500 | 212.5M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,000,000 | 194.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,885,821 | 183.4M $ | as of Mar 31, 2026 |
Declared shareholders of Revolution Medicines Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 4.90 % | 9,766,496 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Revolution Medicines Inc
12 funds declare 12 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| NYLI MacKay Convertible Fund | 1 | 18.9M $ | as of Apr 30, 2026 |
| Calamos Growth & Income Fund | 1 | 12.3M $ | as of Apr 30, 2026 |
| Calamos Market Neutral Income Fund | 1 | 6M $ | as of Apr 30, 2026 |
| Calamos Convertible Fund | 1 | 5M $ | as of Apr 30, 2026 |
| Putnam Convertible Securities Fund | 1 | 4.6M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 3.3M $ | as of Apr 30, 2026 |
| Calamos Global Opportunities Fund | 1 | 1.6M $ | as of Apr 30, 2026 |
| Miller Market Neutral Income Fund | 1 | 753K $ | as of Apr 30, 2026 |
| First Trust SSI Strategic Convertible Securities ETF | 1 | 568.2K $ | as of Apr 30, 2026 |
| Calamos Global Convertible Fund | 1 | 402K $ | as of Apr 30, 2026 |
| Janus Henderson Income ETF | 1 | 344.5K $ | as of Apr 30, 2026 |
| Miller Convertible Total Return ETF | 1 | 55.8K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of Revolution Medicines Inc". https://titelia.com/en/stocks/revolution-medicines-inc-US76155X1000